MLYS Earnings & Financial Statements
Mineralys Therapeutics, Inc.
$21.64
+$0.88(+4.24%)
36
Overall
55
Value
18
Tech
36
Quality
Market Cap
$1.84B
Volume
1.09M
52W Range
$21.46 - $47.65
Target Price
$48.50
MLYS earnings and financial statements: Mineralys Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
MLYS Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | -$170.60M | -$192.40M | -$84.66M |
| EBITDA | -$170.59M | -$192.35M | -$71.90M |
| Net income | -$154.70M | -$177.81M | -$71.90M |
| EPS (diluted) | $-2.29 | $-3.66 | $-1.99 |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total assets | $661.81M | $205.90M | $251.64M |
| Total liabilities | $15.11M | $14.65M | $10.48M |
| Shareholders’ equity | $646.69M | $191.26M | $241.15M |
| Cash and equivalents | $172.92M | $114.09M | $49.30M |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating cash flow | -$142.42M | -$166.31M | -$81.17M |
| Capital expenditure | -$15.0K | -$96.0K | - |
| Free cash flow | -$142.43M | -$166.41M | -$81.17M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLYS | $21.64 | +4.2% | 1.09M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mineralys Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW